{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:14:46Z","timestamp":1778930086529,"version":"3.51.4"},"reference-count":4,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,9,22]],"date-time":"2024-09-22T00:00:00Z","timestamp":1726963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Obesity"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>People with excess weight and obesity compose 64.5% of the Ecuadorian population. The Allurion Intragastric Balloon (IGB) is a noninvasive weight loss alternative for patients ineligible for other bariatric procedures. The impact of the procedure on weight loss and body composition, along with insertion complications and secondary effects were investigated. This is a single\u2010centre retrospective study of patients who underwent Allurion IGB insertion from July 2020 to March 2021. This study followed 167 patients for 12\u2009months after EIGB insertion. Our sample had a mean initial weight of 83.6\u2009\u00b1\u200913.8\u2009kg and initial body mass index of 31.3\u2009\u00b1\u20093.6\u2009kg\/m<jats:sup>2<\/jats:sup>. Percentage total weight loss was 4.65%\u2009\u00b1\u20090.56%, 8.5%\u2009\u00b1\u20094%, 12.29%\u2009\u00b1\u20094.65%, 15.68%\u2009\u00b1\u20095.22%, 17.14%\u2009\u00b1\u20096.05%, and 14.68%\u2009\u00b1\u200918.02% for months 1, 2, 3, 4, 6 and 12, respectively. In the fourth month, 92 patients (56.4%) had lost \u226550% excess body weight; at month 6, 104 patients (67.5%) achieved this goal. Regarding body composition, body fat percentage started at 38.99%\u2009\u00b1\u20097.92%, and at month 6 was 35.67%\u2009\u00b1\u20096.84%, this was the only significance in the statistical analysis.This study aligns with the literature's safety and efficacy results for the Allurion IGB while illustrating the need for further research regarding weight behaviour after its expulsion.<\/jats:p>","DOI":"10.1111\/cob.12705","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T06:07:05Z","timestamp":1727071625000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of the swallowable Allurion intragastric balloon on body weight and composition: An Ecuadorian experience"],"prefix":"10.1111","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4981-7618","authenticated-orcid":false,"given":"Bernarda","family":"Pati\u00f1o Araujo","sequence":"first","affiliation":[{"name":"Cl\u00ednica Bari\u00e1trica Dr. Napole\u00f3n Salgado  Quito Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1876-9501","authenticated-orcid":false,"given":"Karla Elizabeth","family":"Duque J\u00e1come","sequence":"additional","affiliation":[{"name":"Cochrane Central Executive Team Cochrane Geographic Groups and Fields  Oakham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3039-3190","authenticated-orcid":false,"given":"Mar\u00eda Emilia","family":"Salgado B\u00e1ez","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Bari\u00e1trica Dr. Napole\u00f3n Salgado  Quito Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3033-1265","authenticated-orcid":false,"given":"Gabriel","family":"Villavicencio Logro\u00f1o","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Bari\u00e1trica Dr. Napole\u00f3n Salgado  Quito Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1198-0833","authenticated-orcid":false,"given":"Napole\u00f3n","family":"Salgado Mac\u00edas","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Bari\u00e1trica Dr. Napole\u00f3n Salgado  Quito Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,9,22]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"10","volume-title":"Resumen ejecutivo encuesta STEPS Ecuador 2018","author":"Costa R","year":"2018"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04539-8"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-018-03671-w"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04522-3"}],"container-title":["Clinical Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cob.12705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T03:13:12Z","timestamp":1736305992000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,22]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/cob.12705"],"URL":"https:\/\/doi.org\/10.1111\/cob.12705","archive":["Portico"],"relation":{},"ISSN":["1758-8103","1758-8111"],"issn-type":[{"value":"1758-8103","type":"print"},{"value":"1758-8111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,22]]},"assertion":[{"value":"2024-07-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e12705"}}